Stanford Cancer Institute Directory

Population Sciences Profiles

Showing 11 - 20 of 37
    Assistant Professor (Research) of Neurosurgery and of Medicine (Biomedical Informatics)
    Sr Research Engineer, Medicine - Stanford Prevention Research Center Sr Research Scholar, Medicine - Med/Stanford Prevention Research Center
    Associate Professor (Research) of Medicine (Biomedical Informatics), of Biomedical Data Science and of Surgery

    Bio

    Dr Hernandez-Boussard is an Associate Professor in Medicine (Biomedical Informatics), Biomedical Data Science, and Surgery at the Stanford University School of Medicine. Dr. Hernandez-Boussard's background and expertise is in the field of computational biology, with concentration on accountability measures, population health, and health policy. A key focus of her research is the application of novel methods and tools to large clinical datasets for hypothesis generation, comparative effectiveness research, and the evaluation of quality healthcare delivery.
    Professor (Research) of Medicine (Stanford Prevention Research Center/Cancer Institute) and, by courtesy, of Health Research and Policy (Epidemiology)

    Bio

    Dr. Hsing is a professor of medicine at Stanford University and a co-leader of the Population Sciences Program at Stanford Cancer Institute. A senior fellow for the Center for Innovation in Global Health at Stanford University, Dr. Hsing has conducted population-based epidemiological studies on four continents, including North and South America, Asia, Africa, and Europe. She is a leading expert in the epidemiology and etiology of prostate, hepatobiliary, and thyroid cancers as well as in hormonal carcinogenesis and circadian rhythm. Throughout her 22-year tenure at National Cancer Institute, Dr. Hsing developed extensive expertise in molecular epidemiology, global oncology, cancer prevention, and population-based studies in international settings. She has served on numerous committees and advisory boards, most recently as a member of the Editorial Board of Cancer Epidemiology, Biomarkers & Prevention and as an academic editor of PLOS ONE. She also has served as an adjunct professor in the Department of Epidemiology and the Department of Urology at the George Washington University in Washington, D.C., as well as in the Department of Public Health of Fu Jen Catholic University’s School of Medicine in Taiwan. Dr. Hsing has authored more than 270 peer-reviewed articles, written seven book chapters, and mentored over 50 post-doctoral fellows and scholars. Dr. Hsing currently serves as PI on the following funded projects: • A pilot study to assess the feasibility of building a population-based cancer registry in Accra, Ghana; • A study to assess patterns and trends of liver cancer in the Greater Bay area and in California and to project liver cancer burden in 20 years; • A pilot study in the Bay area to investigate non-viral factors of liver cancer; • A pilot study to investigate the clinical utility of ctNDA in post-treatment surveillance of liver cancer in Mongolia; • A whole genome sequencing study of aggressive thyroid cancer to identify novel prognostic factors; • A cohort study of 10,000 healthy individuals in Taiwan to investigate social and biochemical determinants of wellness (WELL Taiwan); • A cohort study of 10,000 healthy individuals in China to investigate social and biochemical determinants of wellness (WELL China); • A multiethnic cohort study of 550,000 individuals in Singapore to investigate social and biochemical determinants of wellness (WELL Singapore) She also serves as the Stanford PI of a consortium study of a genome-wide association study (GWAS) of prostate cancer in the African countries of Ghana, Senegal, Nigeria, and South Africa. More recently, her her work involves big data studies using such resources as the National Health Insurance Research Database, SEER-Medicare, and other large administrative claims and medical record databases to identify clinically relevant questions to help inform clinical practice.
    C. F. Rehnborg Professor in Disease Prevention in the School, Professor of Medicine, of Health Research and Policy (Epidemiology) and by courtesy, of Statistics and of Biomedical Data Science

    Bio

    C.F. Rehnborg Chair in Disease Prevention at Stanford University, Professor of Medicine, Professor of Health Research and Policy, and Professor (by courtesy) of Biomedical Data Science at the School of Medicine; Professor (by courtesy) of Statistics at the School of Humanities and Sciences; co-Director, Meta-Research Innovation Center at Stanford; Director of the PhD program in Epidemiology and Clinical Research. Born in New York City in 1965 and raised in Athens, Greece. Valedictorian (1984) at Athens College; National Award of the Greek Mathematical Society (1984); MD (top rank of medical school class) from the National University of Athens in 1990; also received DSc in biopathology from the same institution. Trained at Harvard and Tufts (internal medicine and infectious diseases), then held positions at NIH, Johns Hopkins and Tufts. Chaired the Department of Hygiene and Epidemiology, University of Ioannina Medical School in 1999-2010 (tenured professor since 2003) while also holding adjunct professor positions at Harvard School of Public Health, Tufts, and Imperial College. Senior Advisor on Knowledge Integration at NCI/NIH (2012-6). Served as President, Society for Research Synthesis Methodology, and editorial board member of many leading journals (including PLoS Medicine, Lancet, Annals of Internal Medicine, JNCI, Science Translational Medicine, Clinical Chemistry, Molecular and Cellular Proteomics, AIDS, IJE, JCE, Clinical Trials, and PLoS ONE, among others) and as Editor-in-Chief of the European Journal of Clinical Investigation (2010-now). Delivered ~500 invited and honorary lectures. Recipient of many awards (e.g. European Award for Excellence in Clinical Science [2007], Medal for Distinguished Service, Teachers College, Columbia University [2015], Chanchlani Global Health Award [2017], Epiphany Science Courage Award [2018]). Inducted in the Association of American Physicians (2009), European Academy of Cancer Sciences (2010) American Epidemiological Society (2015), European Academy of Sciences and Arts (2015). Honorary titles from FORTH (2014) and Ioannina (2015) and honorary doctorates from Rotterdam (2015) and Athens (2017). Multiple honorary lectureships/visiting professorships (Caltech, Oxford, LSHTM, Yale, U Utah, U Conn, UC Davis, U Penn among others). The PLoS Medicine paper on “Why most published research findings are false” has been the most-accessed article in the history of Public Library of Science (>2.5 million hits). Author of 7 literary books in Greek, two of which (“Toccata for the Girl with the Burnt Face” (Kedros 2012) and “Variations on the Art of the Fugue and a Desperate Ricercar” (Kedros 2014)) were shortlisted for best book of the year Anagnostis awards. Brave Thinker scientist for 2010 according to Atlantic, “may be one of the most influential scientists alive”. Author of ~1000 papers in peer-reviewed journals, 67% of papers as single/first/last author. Highly Cited Researcher according to Thomson Reuters in both Clinical Medicine and in Social Sciences. Citation indices: h=167, m=7 per Google Scholar (h=136 per WoS and Scopus). Current citation rates: >3,000 new citations per month per Google Scholar, >1,500 new citations per month per Scopus or Web of Knowledge. Current citation rates suggest that I am among the 10 scientists worldwide who are currently the most commonly cited, perhaps also the currently most-cited physician. This probably only proves that citation metrics are highly unreliable, since I estimate that I have been rejected over 1,000 times in my life. Regardless, I consider myself privileged to have learned and to continue to learn from interactions with students and young scientists (of all ages) from all over the world and I love to be constantly reminded that I know next to nothing.
    Professor (Research) of Medicine (Oncology)

    Bio

    Dr. Esther John is a cancer epidemiologist and her research focuses on etiology and prognosis of breast and prostate cancer, to better understand lifestyle, hormonal and genetic causes and outcomes of these common cancers, with a special interest in understanding cancer health disparities and cancer in Hispanics and African Americans, two understudied populations.
    Professor of Health Research and Policy (Epidemiology) and of Medicine (Stanford Prevention Research Center)

    Bio

    Recipient of the Outstanding Scientific Contributions in Health Psychology Award from the American Psychological Association, Dr. King's research focuses on the development, evaluation, and translation of public health interventions to reduce chronic disease. Her current research focuses on expanding the reach and generalizability of evidence-based interventions through use of state-of-the-art communication technologies; community-based participatory research perspectives to address health disparities among disadvantaged populations; and policy-level approaches to health promotion. She has served on a number of government taskforces in the U.S. and abroad, including membership on the U.S. Department of Health and Human Services’ Scientific Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020, and the Science Board of the U.S. President’s Council on Fitness, Sports and Nutrition. An elected member of the Academy of Behavioral Medicine Research and Past President of the Society of Behavioral Medicine, in 2014 she received honors from the Association of American Medical Colleges (AAMC) for outstanding research targeting health inequities. Her research on Citizen Science engagement to promote healthful living environments for All was honored in 2015 with an international excellence award. She has received the Society of Behavioral Medicine’s Distinguished Research Mentor Award, and has twice received the Stanford Prevention Research Center’s Outstanding Contributions to Teaching Award.
    Associate Professor of Medicine (Oncology) and of Health Research and Policy at the Stanford University Medical Center

    Bio

    Allison W. Kurian, M.D., M.Sc. is an Associate Professor of Medicine and of Health Research and Policy at Stanford University School of Medicine. She received her medical degree from Harvard Medical School, trained as a resident in Internal Medicine at the Massachusetts General Hospital, and completed her fellowship training in Medical Oncology along with a master’s degree in Epidemiology at Stanford University. As Director of the Stanford Women’s Clinical Cancer Genetics Program, Dr. Kurian's clinical practice centers on women at high risk for developing breast and gynecologic cancers. Dr. Kurian’s research focuses on the identification of women with elevated breast and gynecologic cancer risk, and on the development and evaluation of novel techniques for early cancer detection and risk reduction. One current area of investigation is the utility of next-generation sequencing technology for clinical decision-making. Dr. Kurian's research has been supported by the National Cancer Institute, the Komen Foundation, the American Society of Clinical Oncology, the California Breast Cancer Research Program, the Cancer Research and Prevention Foundation, the Robert Wood Johnson Foundation, and the Breast Cancer Research Foundation.
    Professor of Medicine (Gastroenterology and Hepatology) at the Stanford University School of Medicine

    Bio

    Dr. Uri Ladabaum serves as director of the Gastrointestinal Cancer Prevention Program and heads the Clinical Service of the Division of Gastroenterology and Hepatology at Stanford University School of Medicine. Dr. Ladabaum received his medical degree from the University of California, San Francisco, completed his residency and chief residency in internal medicine at Stanford University Hospital, and fellowship in gastroenterology at the University of Michigan, where he also obtained a M.S. degree in clinical research design and statistical analysis. He returned to the Bay Area in 1999 as a faculty member at the University of California, San Francisco, and joined the Stanford faculty in 2009. Dr. Ladabaum's research focus is colorectal cancer risk management and prevention, including screening, risk stratification, and management of average-risk as well as high-risk populations, including persons with Lynch syndrome. His clinical efforts include providing consultation and screening and surveillance endoscopic services for average risk and high-risk persons, and caring for patients and families with suspected or established inherited cancer predisposition syndromes, including Lynch syndrome and polyposis syndromes. In addition, Dr. Ladabaum provides general gastroenterology consultation and endoscopic services. Dr. Ladabaum's research program spans a range of methods and approaches including epidemiological studies, observational and interventional clinical studies, systematic reviews, decision analyses and health economic evaluations. Current efforts include exploring colorectal cancer screening tailored to risk, and enhancing the uptake of genetic testing and preventive interventions.
    Associate Professor of Medicine (Endocrinology) and, by courtesy, of Health Research and Policy (Epidemiology) at the Palo Alto Veterans Affairs Health Care System

    Bio

    Chief Medical Officer, Palo Alto Cooperative Studies Program Coordinating Center, Veterans Health Administration (VHA) Deputy Associate Chief of Staff for Research and Development, VA Palo Alto Health Care System Site Co-Director, BD-STEP (VA & NCI Big Data Scientist Training & Enhancement Program), VA Palo Alto Health Care System Chair, VISN21 Pharmacy Benefits Management Endocrine Task Force, VHA INTERESTS: Population health, individual precision health, healthcare system management and quality in clinical practice Molecular/genetic epidemiology, health services, big data health applications, patient centered decision making Novel scalable clinical/translational study designs and methods to enhance efficiency and effectiveness Use of electronic health records (EHR) and other data sources Endocrinology and Metabolism (cardiometabolic diseases and glycemic dysregulation, bone and body composition, cancers, thyroid) Aging and hormonal/metabolic transitions and dynamics

Affiliations

Organizations